Charles W. Bolten

发表

Adrenal corticosteroids, their receptors and hypertension

X. Hu, Charles W. Bolten, 2006 .

Early cardiac mineralocorticoid receptor-regulated genes: identifying the not so usual suspects.

M. Heron, Charles W. Bolten, 2006, Endocrinology.

Insulin Sensitizing Pharmacology of Thiazolidinediones Correlates with Mitochondrial Gene Expression rather than Activation of PPARγ

R. Mazzarella, J. Colca, Martin F. Meier, 2007, Gene regulation and systems biology.

Discovery of 3-Cyano- N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1 H-pyrrolo[2,3- b]pyridin-5-yl)benzamide: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor C2 Inverse Agonist.

David C. Wood, K. Fennell, R. Kurumbail, 2018, Journal of medicinal chemistry.

Induction of Human Liver X Receptor α Gene Expression Via an Autoregulatory Loop Mechanism

Suzhen Li, Chunsheng Xia, D. Lala, 2002 .

A Number of Marketed Dihydropyridine Calcium Channel Blockers Have Mineralocorticoid Receptor Antagonist Activity

J. Blinn, M. Payne, J. Funder, 2008, Hypertension.

Thiazolidinediones inhibit the progression of established hypertension in the Dahl salt-sensitive rat

J. Colca, E. Gulve, A. Hromockyj, 2007, Diabetes & vascular disease research.

Mineralocorticoid receptors and vascular inflammation: new answers, new questions.

R. Barve, P. Blanner, C. Bolten, 2007, Endocrinology.

Induction of human liver X receptor alpha gene expression via an autoregulatory loop mechanism.

Suzhen Li, Chunsheng Xia, D. Lala, 2002, Molecular endocrinology.

Lipophilicity as a determinant of thiazolidinedione action in vitro: findings from BLX-1002, a novel compound without affinity to PPARs.

A. Luger, C. Fürnsinn, K. Staniek, 2011, American journal of physiology. Cell physiology.

A Number of Marketed Dihydropyridine Calcium Channel Blockers Have Mineralocorticoid Receptor Antagonist Activity

J. Blinn, M. Payne, J. Funder, 2008, Hypertension.